Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $527.73M Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 2.97% Avg Daily Range (30 D): $0.26 | 3.58% Avg Daily Range (90 D): $0.44 | 3.45% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): 2.82M Avg Daily Volume (90 D): 1.94M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 2,944 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.65M Avg Inst. Trade (90 D): $1.89M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.68M Avg Closing Trade (30 D): $2.05M Avg Closing Trade (90 D): $2.4M Avg Closing Volume: 73.65K         News May 6, 2025 @ 10:00 PM Kirby McInerney LLP Announces Investigation of Cla... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Apr 4, 2025 @ 11:00 AM Arvinas Presents First-in-Human Data for Investiga... Source: N/A Mar 27, 2025 @ 11:00 AM Arvinas Announces Oral Presentation at 2025 Intern... Source: Arvinas, Inc. Jan 21, 2025 @ 9:29 AM 2 Growth Stocks That Could Rocket Higher in the Fi... Source: Cory Renauer Financials   TTM Q1 2025 Q3 2024 Basic EPS $1.14 $-.68 Diluted EPS $1.14 $-.68 Revenue $ $ 188.8M $ 102.4M Gross Profit $ $ $ Net Income / Loss $ $ 82.9M $ -49.2M Operating Income / Loss $ $ 71.4M $ -60.3M Cost of Revenue $ $ $ Net Cash Flow $ $ -19.5M $ -75.1M PE Ratio